Cytek Biosciences, Inc. · NASDAQ:CTKB
McCombe William D. exercised options for 25,719 Cytek Biosciences, Inc. shares (Form 4)
Traded May 18, 2026 · Filed May 20, 2026
On May 18, 2026, McCombe William D. (Chief Financial Officer) exercised options for 25,719 Cytek Biosciences, Inc. shares, leaving 111,177 shares. Filed May 20, 2026 (Form 4).
- Options exercised
- 25,719 shares
- Holding after
- 111,177 shares
- Trading plan
- No
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 18, 2026 | Common Stock | Option exercise | 6,320 | 101,007 | Direct | |
| May 18, 2026 | Common Stock | Shares withheld for tax | 2,268 | US$3.55 | 98,739 | Direct |
| May 18, 2026 | Common Stock | Option exercise | 8,700 | 107,439 | Direct | |
| May 18, 2026 | Common Stock | Shares withheld for tax | 3,122 | US$3.55 | 104,317 | Direct |
| May 18, 2026 | Common Stock | Option exercise | 10,699 | 115,016 | Direct | |
| May 18, 2026 | Common Stock | Shares withheld for tax | 3,839 | US$3.55 | 111,177 | Direct |